N@N

Obagi Medical Joins Save the Childrena?s Japan Relief Efforts

^{Published on 2011-05-12 13:20:26 - Market Wire}
 

LONG BEACH, Calif.--([ BUSINESS WIRE ])--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today that they will match donations to Save the Childrena™s Japan earthquake and tsunami relief fund through the month of May.

"The devastation in Japan has affected us all, and as an organization we felt a need to take action"

aThe devastation in Japan has affected us all, and as an organization we felt a need to take action,a Al Hummel, President and CEO said. aWe hope that our business partners and users of Obagi products will join us in contributing to Save the Childrena™s efforts in Japan.a

Obagi is utilizing Facebook to provide an easya"and easily shareda"way for people to make their donations. By visiting [ http://www.facebook.com/ObagiMedicalProducts?sk=app_180817178633898 ] anyone can make a difference in the lives of affected Japanese children and families.

For each dollar donated, Obagi will match the contribution and donate the same amount, up to a combined total of $50,000, to Save the Children. This will help provide immediate disaster relief and aid long-term recovery plans to rehabilitate childcare centers and help children return to school in ravaged communities. Save the Children will continue to provide children who lived through the disaster with safe places to play and recover.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm D©colletage System, Obagi Rosaclear® System, Obagi ELASTILasha" Eyelash Solution, Obagi Blue Peel RADIANCE^TM, and Nu-Derm® Sun Shield SPF 50. Visit [ www.obagi.com ] for information.

About Save the Children

Save the Children is the leading independent organization creating lasting change for children in need in the United States and around the world. For more information, visit[ www.savethechildren.org ].

Save the Children USA is a member of the International Save the Children Alliance, a global network of 29 independent Save the Children organizations working to ensure the well-being and protection of children in more than 120 countries.

Blue Peel RADIANCE, ELASTIlash and Penetrating Therapeutics are trademarks, and Obagi, Blue Peel, Condition & Enhance, ELASTIderm, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.